Fusion Pharm (FSPM) Osake Kurssi
Fusion Pharm Kurssi
Fusion Pharmn liikevaihto on supistunut 12,1 % vuodessa viimeisten 18 vuoden aikana 808 400,00 USD:een. Fusion Pharmn nettomarginaali on nyt 32,8 %, noussut −28,5 %:sta muutama vuosi sitten.
Fusion Pharm osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Fusion Pharm liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Fusion Pharm -osakkeesta
The business model of Fusion Pharm Inc is centered around providing innovative vertical farming solutions. The company designs and manufactures state-of-the-art cultivation systems known as PharmPods, which are fully equipped shipping containers for growing produce in a controlled environment. Fusion Pharm's business model aims to revolutionize the agriculture industry by offering efficient and sustainable farming solutions that optimize space, resources, and yields. With its cutting-edge technology and expertise in vertical farming, Fusion Pharm Inc aims to meet the increasing demand for locally grown, pesticide-free, and high-quality food products.
Fusion Pharm Inc is primarily active in the industries of horticulture, agriculture, and cannabis cultivation.
The main competitors of Fusion Pharm Inc in the market include companies like GrowLife Inc, Terra Tech Corp, and MedMen Enterprises Inc.
Fusion Pharm Inc, now known as Pharmagreen Biotech Inc, is a Canadian cannabis company. Founded in 2011, Fusion Pharm initially focused on providing vertical farming solutions for growing medicinal herbs and leafy greens. However, in 2018, the company shifted its focus to the cannabis industry and rebranded as Pharmagreen Biotech. With a mission to revolutionize the cannabis cultivation industry, Pharmagreen specializes in the development and licensing of tissue culture plantlets. Through their proprietary technology, the company aims to produce genetically superior, disease-free plantlets while reducing cultivation costs and enhancing overall yields. Pharmagreen Biotech Inc continues to innovate and contribute to the advancement of the cannabis sector.
Fusion Pharm Inc has achieved several significant milestones. The company successfully developed and patented its proprietary PharmPods™ technology, which revolutionizes the cultivation of organic produce and medicinal plants. Fusion Pharm Inc also established strategic partnerships with leading horticultural and agricultural companies, enabling widespread adoption of their innovative growing systems. Additionally, the company expanded its operations internationally, reaching markets in Europe, Asia, and the Americas. Fusion Pharm Inc's dedication to sustainable and efficient cultivation methods has garnered accolades and recognition within the industry. These achievements highlight Fusion Pharm Inc's commitment to advancing the field of indoor agriculture.
Fusion Pharm Inc is primarily present in the United States.
Fusion Pharm Inc represents values of innovation, sustainability, and growth in the agricultural industry. With a focus on providing cutting-edge vertical farming technologies, the company aims to revolutionize traditional farming practices. Fusion Pharm Inc believes in the importance of environmentally friendly solutions that maximize crop production while minimizing resource usage. By fostering partnerships and collaborations, Fusion Pharm Inc strives to create a global network of sustainable farming systems. With a commitment to advancing the future of agriculture, Fusion Pharm Inc is dedicated to providing efficient and profitable solutions for farmers around the world.
Nykyisellä valuuttakurssilla Fusion Pharm-osake noteerataan hintaan 0,00 EUR (0,00 USD).
Fusion Pharm Inc is a company that operates in various business areas, including the manufacturing of greenhouses, production of primarily organic supplements, and offering consulting services for agriculture and construction.
Liikevaihtoa ei voida laskea Fusion Pharm:lle tällä hetkellä.
Voittoa ei voida laskea Fusion Pharm:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Fusion Pharm:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Fusion Pharm:lle tällä hetkellä.
Fusion Pharm:n Eulpool-laatuscore on 3/10.
Fusion Pharm:n ISIN on US36113H1005. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Fusion Pharm:n WKN on A1H9CD. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Fusion Pharm:n ticker on FSPM. Tämä pörssinoteeraus käytetään Fusion Pharm-osakkeiden kauppaan pörssissä.
Fusion Pharm osake
Fusion Pharm vertaisryhmä
Fusion Pharm Ticker
Fusion Pharm FIGI
Kaikki tunnusluvut ja syvällinen analyysi Fusion Pharm:sta
Meidän osakeanalyysimme Fusion Pharm-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Fusion Pharm:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: